Evidence map›Paper›PMID 40751704›Full record

ArticleAmerican journal of hematology2025

The Impact of Tirabrutinib Monotherapy for the Treatment of Bing-Neel Syndrome: A Multicenter Retrospective Study.

Masuho Saburi, Taro Masunari, Noriko Fukuhara, Yuichiro Inagaki, Arika Shimura, Naoto Imoto, Yuta Hasegawa, Masao Hagihara, Nobuhiko Kobayashi, Hanae Kumekawa and 10 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in American journal of hematology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Masuho SaburiDepartment of Hematology, Oita Prefectural Hospital, Oita, Japan.ORCID https://orcid.org/0000-0001-6097-5633
Taro MasunariDepartment of Hematology, Chugoku Central Hospital, Fukuyama, Japan.ORCID https://orcid.org/0000-0002-9952-022X
Noriko FukuharaDepartment of Hematology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Yuichiro InagakiDepartment of Hematology and Oncology, Anjo Kosei Hospital, Anjo, Japan.
Arika ShimuraDepartment of Hematology and Oncology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Naoto ImotoDepartment of Hematology and Oncology, Toyohashi Municipal Hospital, Toyohashi, Japan.
Yuta HasegawaDepartment of Hematology, Hokkaido University Hospital, Sapporo, Japan.
Masao HagiharaDepartment of Hematology, Eiju General Hospital, Tokyo, Japan.
Nobuhiko KobayashiDepartment of Hematology, Gunma University Graduate School of Medicine, Gunma, Japan.
Hanae KumekawaDepartment of Hematology, Tokyo Teishin Hospital, Tokyo, Japan.
Hideyuki NakazawaDepartment of Hematology, Shinshu University School of Medicine, Matsumoto, Japan.
Kana MiyazakiDepartment of Hematology and Oncology, Mie University Graduate School of Medicine, Tsu, Japan.
Toshiro KawakitaDepartment of Hematology, NHO Kumamoto Medical Center, Kumamoto, Japan.
Takahiro IsshikiDepartment of Hematology, Tsukuba Memorial Hospital, Ibaraki, Japan.
Atsushi KatsubeDepartment of Clinical Oncology/Hematology, The Jikei University School of Medicine, Tokyo, Japan.
Shin FujisawaDepartment of Hematology, Yokohama City University Medical Center, Yokohama, Japan.ORCID https://orcid.org/0000-0003-2028-0209
Yuichi HorigomeDepartment of Hematology, Kitasato University School of Medicine, Kanagawa, Japan.
Yusuke KobaDepartment of Hematology Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
Fumiaki JinnouchiDepartment of Hematology, Kyushu University Hospital, Fukuoka, Japan.
Naohiro SekiguchiDepartment of Hematology, NHO Disaster Medical Center, Tokyo, Japan.ORCID https://orcid.org/0000-0001-9860-8257

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Bing‐Neel syndrometirabrutinibWaldenström macroglobulinemia

Identifiers

PMID40751704
PMCPMC12417752

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.